Protective effect of Salvia Miltiorrhiza Injection on myocardial injury in rats with haemorrhagic shock resuscitated by HBOC-CHP01
Source abstract
Abstract
This study investigated whether Salvia Miltiorrhiza Injection (SMI) could mitigate acute myocardial injury following resuscitation from severe haemorrhagic shock with the hemoglobin-based oxygen carrier HBOC-CHP01. Network pharmacology was first used to predict SMI's potential mechanisms. In vivo, a 50% severe haemorrhagic shock model was induced in rats, which were then resuscitated with either HBOC-CHP01 alone (n=12) or HBOC-CHP01 plus SMI (8.0 ml/kg, n=12). Subgroups were assessed for 72-hour survival, blood parameters, and myocardial tissue injury at 24 hours post-resuscitation. Network pharmacology identified 189 potential targets, with AKT1, CASP3, and HIF-1α among the core candidates. In vivo, while 72-hour survival was unchanged, SMI significantly reduced plasma cardiac injury markers (AST, LDH, CK, cTnI) at 24 hours post-resuscitation compared to HBOC-CHP01 alone. Histological analysis revealed markedly reduced myocardial inflammation and apoptosis in the SMI-treated group. This cardioprotection was associated with significant upregulation of myocardial Nrf2 and HO-1, alongside reduced reactive oxygen species and myeloperoxidase levels. In conclusion, SMI reduces myocardial injury after HBOC-CHP01 resuscitation in haemorrhagic shock rats, primarily by activating the Nrf2/HO-1 antioxidant pathway, suggesting its potential as an adjunctive therapy to improve the safety of hemoglobin-based oxygen carriers.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hemoglobin structure and function · Medicinal Plants and Bioactive Compounds · Hydrogen's biological and therapeutic effects
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College
Funding
Chinese Academy of Medical Sciences · Sichuan Provincial Administration of Traditional Chinese Medicine
References (25)
Show source-provided references
1. 10.55460/ovop-v2qc10.55460/ovop-v2qc ↗
2. 10.1053/j.seminhematol.2019.11.00610.1053/j.seminhematol.2019.11.006 ↗
3. 10.3390/medicina5902039610.3390/medicina59020396 ↗
4. 10.1213/ANE.000000000000395710.1213/ANE.0000000000003957 ↗
5. 10.3389/fmed.2021.79456110.3389/fmed.2021.794561 ↗
6. 10.1111/trf.1372610.1111/trf.13726 ↗
7. 10.1111/j.1537-2995.2009.02356.x10.1111/j.1537-2995.2009.02356.x ↗
8. 10.1001/jama.299.19.jrv8000710.1001/jama.299.19.jrv80007 ↗
9. 10.1016/j.tibtech.2014.02.00610.1016/j.tibtech.2014.02.006 ↗
10. 10.1097/SHK.000000000000104410.1097/SHK.0000000000001044 ↗
11. 10.3390/antiox909085710.3390/antiox9090857 ↗
12. 10.7150/thno.5317010.7150/thno.53170 ↗
13. 10.3892/etm.2019.746210.3892/etm.2019.7462 ↗
14. 10.3109/21691401.2012.74499510.3109/21691401.2012.744995 ↗
15. 10.3109/21691401.2014.93445510.3109/21691401.2014.934455 ↗
16. ANIMALS N R C U C F T U O T G F T C A U O L (Committee for the Update of the Guide for the Care and Use of Laboratory Animals). Guide for the care and use of laboratory animals. Washington (DC); 2011.
17. 10.3389/fmedt.2022.104895110.3389/fmedt.2022.1048951 ↗
18. 10.1080/21691401.2024.236744410.1080/21691401.2024.2367444 ↗
19. 10.1155/2020/201803510.1155/2020/2018035 ↗
20. 10.3390/pharmaceutics1509223510.3390/pharmaceutics15092235 ↗
21. 10.1186/s13020-024-00908-y10.1186/s13020-024-00908-y ↗
22. 10.3892/ijmm.2017.333810.3892/ijmm.2017.3338 ↗
23. 10.1007/s11596-017-1801-110.1007/s11596-017-1801-1 ↗
24. 10.1016/j.freeradbiomed.2018.01.02410.1016/j.freeradbiomed.2018.01.024 ↗
25. 10.1586/ecp.09.4110.1586/ecp.09.41 ↗